CTT PHARMACEUTICAL HOLDINGS, INC. Earnings Per Share Diluted

Quick Answer

CTT PHARMACEUTICAL HOLDINGS, INC. reported Earnings Per Share Diluted of $0.01 per share for the year ending 2013.

  • CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +109.1% in Earnings Per Share Diluted from 2012 to 2013.
  • This data is from CTT PHARMACEUTICAL HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 10, 2014.
  • XBRL data for this metric is available from 2010 to 2013 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: $0.00 per share | Q3 2010: $0.05 (loss) per share | Q1 2011: $0.62 per share | Q2 2011: $0.12 (loss) per share | Q3 2011: $0.05 (loss) per share | Q1 2012: $0.06 (loss) per share | Q2 2012: $0.00 per share | Q3 2012: $0.01 (loss) per share | Q1 2013: $0.01 (loss) per share | Q2 2013: $0.01 (loss) per share | Q3 2013: $0.00 per share | Q1 2014: $0.00 per share | Q2 2014: $0.00 per share.
  • Over the full 4 years of available data (2010 to 2013), CTT PHARMACEUTICAL HOLDINGS, INC.'s Earnings Per Share Diluted has grown by 107.7%.
  • Historical annual values: Fiscal year 2013: $0.01 per share | Fiscal year 2012: $0.11 (loss) per share | Fiscal year 2011: $0.40 per share | Fiscal year 2010: $0.13 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: